Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
621-635
Author(s):
Ravi D. Rao, Jan C. Buckner and Jann N. Sarkaria
Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
653-671
Author(s):
Hue H. Luu, Ruiwen Zhang, Rex C. Haydon, Elizabeth Rayburn, Quan Kang, Weike Si, Jong Kyung Park, Hui Wang, Ying Peng, Wei Jiang and Tong- Chuan He
Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
689-702
Author(s):
P. Michl and T. M. Gress
Novel Approaches for RNA Interference and their Application in Cancer Therapy
Journal:
Current Pharmacogenomics
Volume:
2
Page:
313-324
Author(s):
Joel B. Berletch, Jessica Green, Amanda P. Cunningham, Lucy G. Andrews and Trygve O. Tollefsbol
Role of the Non-Neuronal Human Cholinergic System in Lung Cancer and Mesothelioma: Possibility of New Therapeutic Strategies
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
535-542
Author(s):
Sonya Trombino, Alessandra Bisio, Alessia Catassi, Alfredo Cesario, Carla Falugi and Patrizia Russo
Antifolates - Past, Present and Future
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
405-410
Author(s):
Aleem Gangjee and Hiteshkumar D. Jain
Antisense Strategies
Journal:
Current Molecular Medicine
Volume:
4
Page:
465-487
Author(s):
Stanley T. Crooke
Small Molecule Toxins Targeting Tumor Receptors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2311-2334
Author(s):
Marcin Dyba, Nadya I. Tarasova and Christopher J. Michejda
Effects of Specific Cyclooxygenase-2 Inhibitors on Carcinogenesis
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
291-295
Author(s):
John W. Ho, Jing Zheng Song and Qian Li
Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
267-283
Author(s):
X. Chen, S. Wang, N. Wu and C. S. Yang